Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin vs Atorvastatin in AMI with Abnormal Glucose Metabolism
NCT04945122Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pitavastatin in acute myocardial infarction (AMI) (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: HbA1c reduction at 6 months. Status: unknown.
02
Drugs
pitavastatin
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT04945122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04945122.